Portfolio company
BioTryp
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops oral antibiofilm therapies to treat bacterial infections for patients, primarily focusing on individuals with urinary tract infections.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
PerioTrap
This company develops anti-infective oral care products, including toothpastes and dental gels, for consumers and dental professionals to treat periodontitis.
AtoCap
This company develops biodegradable microcapsules for targeted drug delivery to treat recurrent infections and bladder cancer for pharmaceutical partners and clinical providers.
TXN Systems
This pharmaceutical company develops a novel class of antibiotics to treat multidrug-resistant urinary tract infections in patients.
MyUTI
This company provides diagnostic laboratory testing kits and telehealth services for individuals suffering from urinary tract infections and related pelvic health issues.
BEO Therapeutics
This company develops oral microbiome therapies to treat patients with gouty arthritis and chronic kidney disease by reducing metabolic waste products.
Iterum Therapeutics
This pharmaceutical company develops and commercialises oral and intravenous antibiotics for patients with multi-drug resistant infections, including urinary tract infections.
SANTERO
This company develops small molecule medicines targeting bacterial dormancy to treat patients with chronic, treatment-refractory respiratory, orthopaedic and wound-related infections.
iFAST Diagnositcs
The company develops rapid antimicrobial susceptibility testing systems for hospitals and clinical laboratories to identify effective antibiotic treatments for bacterial infections.
